A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
Clinical trial NCT05971862 · UNKNOWN
Trial details
- NCT number
- NCT05971862
- Sponsor
- Oscotec Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2024-04-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.